BeOne Medicines (ONC) News Today $297.01 +3.92 (+1.34%) Closing price 04:00 PM EasternExtended Trading$297.50 +0.49 (+0.16%) As of 05:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ONC Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period BeOne Medicines (NASDAQ:ONC) SVP Chan Henry Lee Sells 332 SharesMay 16 at 8:18 AM | insidertrades.comGuggenheim Lifts BeOne Medicines (ONC) Price Target, Keeps Buy RatingMay 14, 2026 | finance.yahoo.comBeOne Medicines Wins Conditional FDA Nod For Cancer Drug In Rare Blood CancerMay 14, 2026 | benzinga.comONC stock gains as BeOne Medicines wins US nod for BEQALZI in rare lymphomaMay 13, 2026 | msn.comBeOne Medicines Gets FDA Accelerated Approval for Lymphoma DrugMay 13, 2026 | marketwatch.comBeOne Medicines' (NASDAQ:ONC) Performance Is Even Better Than Its Earnings SuggestMay 13, 2026 | finance.yahoo.comBeOne Medicines' BEQALZI™ (sonrotoclax) Approved by U.S. FDA as First and Only BCL2 Inhibitor for R/R Mantle Cell LymphomaMay 13, 2026 | businesswire.comBeOne Medicines Ltd (6160) Gets a Buy from CLSAMay 11, 2026 | theglobeandmail.comBeOne Medicines' (ONC) "Buy" Rating Reiterated at Truist FinancialMay 10, 2026 | americanbankingnews.comAnalysts Are Bullish on These Healthcare Stocks: BeOne Medicines (ONC), Alector (ALEC)May 9, 2026 | theglobeandmail.comWall Street Zen Upgrades BeOne Medicines (NASDAQ:ONC) to "Strong-Buy"May 9, 2026 | marketbeat.comEarnings Beat: BeOne Medicines AG Just Beat Analyst Forecasts, And Analysts Have Been Updating Their ModelsMay 8, 2026 | finance.yahoo.comSigma Planning Corp Sells 3,208 Shares of BeOne Medicines Ltd. - Sponsored ADR $ONCMay 8, 2026 | marketbeat.comBeOne Medicines (NASDAQ:ONC) Price Target Raised to $425.00May 7, 2026 | marketbeat.comBeOne Medicines (NASDAQ:ONC) Earns "Buy" Rating from Truist FinancialMay 7, 2026 | marketbeat.comUBS Group AG Grows Stake in BeOne Medicines Ltd. - Sponsored ADR $ONCMay 7, 2026 | marketbeat.comBeOne Medicines Shares Surge After Robust First-QuarterMay 7, 2026 | marketwatch.comBeOne Medicines Q1 Earnings Call HighlightsMay 6, 2026 | marketbeat.comBeOne Medicines AG 2026 Q1 - Results - Earnings Call PresentationMay 6, 2026 | seekingalpha.comBeOne Medicines (NASDAQ:ONC) Raised to "Strong-Buy" at Wells Fargo & CompanyMay 6, 2026 | marketbeat.comWells Fargo initiates coverage of BeOne Medicines AG - depositary receipt (ONC) with overweight recommendationMay 5, 2026 | msn.comDid FDA Fast-Track HER2 Regimen Just Shift BeOne Medicines' (ONC) Investment Narrative?May 5, 2026 | finance.yahoo.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Receives Consensus Recommendation of "Moderate Buy" from AnalystsMay 4, 2026 | marketbeat.comBeOne Medicines to Announce First Quarter 2026 Financial Results on May 6April 22, 2026 | businesswire.comBeOne Medicines AG - Depositary Receipt (ONC) price target increased by 39.38% to 468.82April 16, 2026 | msn.comTruist Financial Remains a Buy on BeOne Medicines (ONC)April 15, 2026 | theglobeandmail.comBeOne Medicines (NASDAQ:ONC) SVP Sells $103,447.88 in StockApril 11, 2026 | insidertrades.comBeOne Medicines Ltd. Sponsored ADRApril 9, 2026 | edition.cnn.comBeOne Medicines price target lowered to $411 from $412 at TruistApril 9, 2026 | finance.yahoo.comIBD rating upgrades: BeOne Medicines ADR shows improved price strengthApril 8, 2026 | msn.comBeOne Medicines (ONC) Is Up 9.4% After FDA Orphan Status And New Analyst Coverage For Liver CancerApril 6, 2026 | finance.yahoo.comBeOne Medicines (ONC) Downgraded Despite Strong Oncology PortfolioApril 2, 2026 | finance.yahoo.comJefferies downgrades BeOne Medicines AG - depositary receipt (ONC)March 17, 2026 | msn.comBeOne Medicines (NASDAQ:ONC) SVP Chan Henry Lee Sells 341 SharesMarch 14, 2026 | insidertrades.comAnalysts Are Bullish on These Healthcare Stocks: Rhythm Pharmaceuticals (RYTM), BeOne Medicines (ONC)March 4, 2026 | theglobeandmail.comBeOne Medicines Ltd (ONC) Q4 2025 Earnings Call Highlights: Record Growth and Strategic ExpansionMarch 4, 2026 | finance.yahoo.comBeOne Medicines: Guidance Weighs But Multiple Catalysts In 2026February 28, 2026 | seekingalpha.comIs It Time To Reassess BeOne Medicines (ONC) After Strong Multi Year Share Price GainsFebruary 26, 2026 | finance.yahoo.comBeOne Medicines AG 2025 Q4 - Results - Earnings Call PresentationFebruary 26, 2026 | seekingalpha.comBeOne Medicines stock falls over 2% as guidance disappoints despite earnings beatFebruary 26, 2026 | investing.comBeOne Medicines Announces Fourth Quarter and Full Year 2025 Financial Results, Highlighting Global Success of BRUKINSA and Foundational Oncology LeadershipFebruary 26, 2026 | businesswire.com3 Brilliant Growth Stocks to Buy Now and Hold for the Long TermFebruary 21, 2026 | fool.com10 High Growth International Stocks to Buy NowFebruary 13, 2026 | insidermonkey.comBeOne Medicines to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26February 11, 2026 | businesswire.comBeOne Medicines (NASDAQ:ONC) SVP Sells $580,203.20 in StockFebruary 7, 2026 | insidertrades.comShould InSysBio Modeling Partnership Expansion Shape How Investors View BeOne Medicines’ (ONC) Oncology Strategy?February 2, 2026 | uk.finance.yahoo.comBeOne Medicines Deepens InSysBio Partnership To Refine Oncology Trial RiskFebruary 2, 2026 | finance.yahoo.comA Look At BeOne Medicines (ONC) Valuation After Recent Mixed Short Term ReturnsFebruary 1, 2026 | finance.yahoo.comRBC Capital Sticks to Their Buy Rating for BeOne Medicines (ONC)February 1, 2026 | theglobeandmail.comWall Street bullish on BeOne Medicines AG (ONC) amid robust pipeline developmentJanuary 31, 2026 | msn.com Get BeOne Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ONC Media Mentions By Week ONC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONC News Sentiment▼0.590.39▲Average Medical News Sentiment ONC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONC Articles This Week▼85▲ONC Articles Average Week Get the Latest News and Ratings for ONC and Related Stocks Enter your email address to receive the latest news and analysts' ratings for BeOne Medicines and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies SNY News GSK News TAK News ARGX News TEVA News RVMD News BNTX News INSM News MRNA News ROIV News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ONC) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BeOne Medicines Ltd. - Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share BeOne Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
